I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Jincheng Pharm announced that its wholly-owned subsidiary Beijing Jincheng Tail Pharmaceutical Co., Ltd. (referred to as "Jincheng Tail") recently received the European Pharmacopoeia suitability certificate for Oseltamivir Phosphate chemical raw materials issued by the European Directorate for the Quality of Medicines (EDQM). Oseltamivir Phosphate is a selective neuraminidase inhibitor for influenza viruses that can inhibit the further spread of the virus in the body, developed by Roche
According to the Zhitong Finance APP, Jincheng Pharm (300233.SZ) announced that its wholly-owned subsidiary Beijing Jincheng Tail Pharmaceutical Co., Ltd. (referred to as "Jincheng Tail") recently received the European Pharmacopoeia suitability certificate for Oseltamivir Phosphate chemical raw materials issued by the European Directorate for the Quality of Medicines (EDQM). Oseltamivir Phosphate is a selective neuraminidase inhibitor for influenza viruses that can inhibit the further spread of the virus in the body, developed by Roche